3Nicholas W, Gale P B. Ephrin-B2 selectively Marks Arterial Vessels and Neovascularization Sites in the Adult, With Expression in Both Endothelial and Smooth-Muscle cells[J]. Dev Biol, 2001,230(2) : 151 - 160.
4Thurston G C, Surl K Smith. Leakage-Resistant Blood Vessels in Mice Trangenically Overexpressing Angiopoientin-1 [ J ]. Science, 1999, 286 ( 5449):2 511 -2 514.
6Peacock D J, Banquerigo M L, Brahn E. Angiogenesis inhibition suppresses collagen arthritis[J]. J Exp Med, 1992,175:1 135- 1 138.
7Storgard C M, Stupack D G, Jonczyk A, et al. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist[J]. J Clin Invest,1999,103 : 47 - 54.
8Griffioen AW, Molema G.Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation[J]. Pharmacol Rev, 2000,52(2) :237 - 268.
9Marriott J B, Muller G, Dalgleish A G. Thalidomide as an emerging immunotherapeutic agent[J]. Immunol Today, 1999,20:538 - 540.
10Sands B E, Podolsky D K. New life in a sleeper: Thalidomide and Crohn's disease[J]. Gastroenterology, 1999,117:1 485- 1 488.
